Innocrin Pharmaceuticals innocrinpharma.com


Public list: Pharma Startups (4740) Cancer Therapeutics (1146)

Innocrin discovers and develops novel, best-in-class oral inhibitors of CYP17 lyase, a validated enzyme target for the treatment of castration-resistant prostate cancer (CRPC). VT-464 and structurally-related classes of CYP17 inhibitors are wholly owned by Innocrin. CYP17 lyase inhibitors may also have high commercial potential for the treatment of breast cancer as well as non-oncologic syndromes that are due to hormonal excess including endometriosis, polycystic ovary syndrome and congenital ad...Show all

Innocrin discovers and develops novel, best-in-class oral inhibitors of CYP17 lyase, a validated enzyme target for the treatment of castration-resistant prostate cancer (CRPC). VT-464 and structurally-related classes of CYP17 inhibitors are wholly ow...Show all

Company (Alive / Active)

Phone: 919-467-8539

Fax:

4505 Emperor Boulevard
Suite 300
Durham, 27703
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Innocrin Pharmaceuticals $42M Jul 13, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Innocrin Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Metalloenzyme inhibitor compounds Aug 27, 2012 Oct 06, 2015 Patent
Metalloenzyme inhibitor compounds Dec 29, 2010 Mar 24, 2015 Patent
Metalloenzyme inhibitor compounds Feb 02, 2017 Application